Etoposide Injection Manufacturer/Supplier and Global Exporter from India
We are the leading suppliers of Etoposide injection (Posiact) to Africa, America, and Asia.
With 10 years of experience in Injectable manufacturing, Aprazer Healthcare is recognized as the top oncology injectable manufacturer from India.
We manufacture a comprehensive range of chemotherapy injectables.
Our top range of anticancer injections includes-
- Carboplatin – Carbokast 450
- Cisplatin- Cycokast 50
- Cytarabine- Cytarzer 1000
- Daunorubicin – Daunozer -20
Etoposide injection and its uses-
Etoposide is a chemotherapy drug.
It is a plant–derived drug called an anti-neoplastic alkaloid.
It is widely used in lung cancer, testicular cancer, and leukemia.
Which brand to choose for Etoposide injection?
Posiact is Etoposide 100mg /5ml.
Manufactured by Aprazer Healthcare, is a global quality formulation.
Affordable and available worldwide, Posiact is the first choice of oncologists.
What is the working of Etoposide injection?
It binds to the DNA.
Inhibits the enzyme and stops the sealing of the DNA strands.
It leads to cancer cell death.
Why is Aprazer Healthcare a leading Etoposide injection exporter?
Aprazer Healthcare manufactures global-quality Etoposide injection.
Adhering to international regulatory standards, we are the trusted global oncology drug exporter.
Global-Quality compliance
- WHO-GMP compliant manufacturing
- In-house quality audits
- Modern technology
Worldwide distribution network-
- Advanced logistics
- Cold chain supply
- Global reach
- Timely delivery
Long-term reliable partnership-
With our transparent and fair dealings, we believe in building long-term relationships.
We are a leading partner to national governments for oncology injectable supplies.
Manufacturing affordable anticancer injections, we are at the front line delivering affordable standard anticancer care worldwide.
End-to-end regulatory support-
Our team of regulatory experts is efficient in navigating the flexible regulatory norms.
- Dossier compilation
- Global approvals and drug registrations
- GDP- compliance
- Custom clearance
Why does Etoposide (Posiact) form a key treatment for lung cancer?
It is the standard chemotherapy drug widely used in small cell lung cancer.
It is widely used due to its ability to destroy rapidly dividing cancer cells.
Lung cancer cells divide rapidly.
Etoposide targets the enzyme and inhibits division.
It is paired with platinum-based drugs to achieve the highest response.
It is also paired with immunotherapy drugs and used in multiple-stage treatment.
What are the typical Etoposide cycle timelines?
The standard treatment regimen consists of 4- 6 cycles.
The treatment lasts for 3-4 months.
Each cycle operates at 21 days (3-week) schedule.
Day 1-3 – The IV infusion is given for 3 consecutive days, and the day-1 infusion is combined with platinum drugs.
Day 2 to 21 – It is the period for rest and recovery.
No treatment is given during these days.
What are the adverse effects of Etoposide injection?
- Bone marrow suppression
- Anemia
- Risk of infections
- GIT distress
- Nausea /vomiting
- Mouth ulcers
- Injection site reaction
Always trust Aprazer Healthcare for effective global quality oncology injectables.
